Shalini Sharp Ultragenyx Pharmaceutical Inc. (RARE) insider trading activity

RARE Quotes by TradingView

Shalini Sharp is EVP, Finance of Ultragenyx Pharmaceutical Inc.. Currently has a direct ownership of 97,812 shares of RARE, which is worth approximately $4.29 Million. The most recent transaction as insider was on Oct 14, 2020, when has been sold 375 shares (Common Stock) at a price of $87.99 per share, resulting in proceeds of $32,996. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 97.8K
0% 3M change
0% 12M change
Total Value Held $4.29 Million

Shalini Sharp Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 14 2020
SELL
Open market or private sale
$32,996 $87.99 p/Share
375 Reduced 0.38%
97,812 Common Stock

Also insider at

BGNE
BeiGene, Ltd. Healthcare
Director
NBIX
NEUROCRINE BIOSCIENCES INC Healthcare
Director
OGN
Organon & Co. Healthcare
Director
MRTX
Mirati Therapeutics, Inc. Healthcare
NUVB
Nuvation Bio Inc. Healthcare
Director
STRO
SUTRO BIOPHARMA, INC. Healthcare
Director
DTIL
PRECISION BIOSCIENCES INC Healthcare
Director
SS

Shalini Sharp

EVP, Finance
San Diego, CA

Track Institutional and Insider Activities on RARE

Follow Ultragenyx Pharmaceutical Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RARE shares.

Notify only if

Insider Trading

Get notified when an Ultragenyx Pharmaceutical Inc. insider buys or sells RARE shares.

Notify only if

News

Receive news related to Ultragenyx Pharmaceutical Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RARE